What is a TASK FORCE?

Our Task Forces are generally composed of Latin American disease experts intended to advance knowledge on epidemiology, availability of, and access to treatment and prevention strategies. Members of the task force communicate, educate and advocate for policy recommendations through meetings with Ministries of Health, regulatory agencies and other relevant public health authorities. These recommendations for public health authorities serve as an invaluable tool for guiding health professionals and private industry, while also serving to educate and build awareness in the public at large. The outcome of our Task Force is a strategic plan to develop, disseminate and educate about recommendations regarding specific health topic.

 

As part of its education initiatives, AHF creates Disease-Specific Task Forces for the purpose of advancing key vaccination and health education topics in Latin America. Specifically, the establishment of Disease-Specific Task Forces aims to promote awareness and increase medical knowledge in the areas of the disease, advance knowledge of the prevalence and burden of the disease and advocate for more effective programs and policies towards increasing prevention and control strategies regarding the disease.

AHF has convened a Task Force in each of these disease areas; these were comprised of clinicians from the Latin American region who specialize in diagnosing and treating each of the targeted diseases. The Disease Task Force Initiative will constitute a series of meetings aimed at multiple audiences in Latin America. The objectives of the Disease Task Force Initiative will be to:

Prepare and discuss the burden of the disease in Latin America and to review the current prevention and control strategies relevant to the disease in Latin American countries.

Define and prepare an action plan for a set time period on the disease regarding prevention and control policies in Latin America, and

Prepare and evaluate recommendations to be presented to the Pan American Health Organization’s (PAHO) 2015 Technical Advisory Group (TAG) meeting on Vaccine-preventable Diseases, if relevant.

 The Disease-Specific Task Force’s formulation of recommendations for public health authorities in the Region serve as an invaluable tool for guiding health professionals and private industry, while also serving to educate and build awareness among the public at large.

VALUE OF INNOVATION

Shaping the Regulatory Environment for Healthcare Innovation in Latin America: Policy Recommendations

February 27, 2025 - Bogotá, Colombia

AHF successfully convened a multi-stakeholder Task Force to develop actionable policy recommendations for improving the regulatory environment for healthcare innovation in Latin America. Experts from Argentina, Brazil, Colombia, and Mexico, representing health economy, policy, academia, and innovation, engaged in a dynamic discussion on key challenges, including access to innovation, pricing regulations, and the economic impact of healthcare investments.

A central focus was the Wait Indicator, assessing the time it takes for medicines to reach the market and their true economic value. The Task Force also examined government regulation vs. market-driven pricing models, aiming to propose a balanced approach that
fosters innovation while ensuring fair access.

The insights gathered will inform a policy paper outlining concrete recommendations to shape a more sustainable and innovation-friendly healthcare ecosystem in the region. This document is pending publication in a policy journal and will serve as a roadmap
for policymakers, industry leaders, and stakeholders committed to advancing health technology innovation in Latin America. Stay tuned.

 

Value of Innovation 2

 

Value Innovation Task Force Meeting Participants:

Moderator: Dr. Mariana Rico

 

Value of Innovation 1